Cargando…

Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy

Radiolabelled melanin ligands offer an interesting strategy for the treatment of disseminated pigmented melanoma. One of these molecules, ICF01012 labelled with iodine 131, induced a significant slowing of melanoma growth. Here, we have explored the combination of [(131)I]ICF01012 with coDbait, a DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viallard, Claire, Chezal, Jean-Michel, Mishellany, Florence, Ranchon-Cole, Isabelle, Pereira, Bruno, Herbette, Aurélie, Besse, Sophie, Boudhraa, Zied, Jacquemot, Nathalie, Cayre, Anne, Miot-Noirault, Elisabeth, Sun, Jian-Sheng, Dutreix, Marie, Degoul, Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914332/ https://www.ncbi.nlm.nih.gov/pubmed/26887045 http://dx.doi.org/10.18632/oncotarget.7340

Ejemplares similares

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms()
por: Akil, Hussein, et al.
Publicado: (2019)

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy()
por: Rbah-Vidal, Latifa, et al.
Publicado: (2016)

Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol
por: Schlegel, Anne, et al.
Publicado: (2012)

Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept
por: Solass, Wiebke, et al.
Publicado: (2011)

Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems
por: Berthault, N, et al.
Publicado: (2011)

Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept
por: Voissiere, Aurélien, et al.
Publicado: (2017)

Distribution and Radiosensitizing Effect of Cholesterol-Coupled Dbait Molecule in Rat Model of Glioblastoma
por: Coquery, Nicolas, et al.
Publicado: (2012)

Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing
por: Voissiere, Aurélien, et al.
Publicado: (2017)

A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model
por: Peyrode, Caroline, et al.
Publicado: (2011)

Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer
por: Maisonial-Besset, Aurelie, et al.
Publicado: (2017)

A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma()
por: Biau, Julian, et al.
Publicado: (2014)

A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs
por: Chao, Maria Noelia, et al.
Publicado: (2022)

Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
por: Thivat, Emilie, et al.
Publicado: (2022)

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models
por: Rondon, Aurélie, et al.
Publicado: (2017)

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
por: Rondon, Aurélie, et al.
Publicado: (2019)

(99m)Tc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
por: Miot-Noirault, Elisabeth, et al.
Publicado: (2013)

Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models
por: Biau, Julian, et al.
Publicado: (2019)

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
por: Cayre, Anne, et al.
Publicado: (2007)

Efficacy of Targeted Radionuclide Therapy Using [(131)I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma
por: Akil, Hussein, et al.
Publicado: (2021)

Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the (64)Cu-Labelling of Immunoconjugates
por: Maisonial-Besset, Aurélie, et al.
Publicado: (2022)

[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
por: Jouberton, Elodie, et al.
Publicado: (2020)

Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011)

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
por: Zaoui, Kossay, et al.
Publicado: (2019)

N-(4-iodophenyl)-N′-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice
por: Borel, M, et al.
Publicado: (2007)

Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin
por: Du, Longhai, et al.
Publicado: (2023)

Radionuclide carriers for targeting of cancer
por: Sofou, Stavroula
Publicado: (2008)

Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018)

A tumor microenvironment-responsive micelle co-delivered radiosensitizer Dbait and doxorubicin for the collaborative chemo-radiotherapy of glioblastoma
por: Zhang, Shuyue, et al.
Publicado: (2022)

Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
por: Bonnet, Mathilde, et al.
Publicado: (2019)

Targeted Radionuclide Therapy of Human Tumors
por: Gudkov, Sergey V., et al.
Publicado: (2015)

Introduction to Radiobiology of Targeted Radionuclide Therapy
por: Pouget, Jean-Pierre, et al.
Publicado: (2015)

Radionuclides for Targeted Therapy: Physical Properties
por: Stokke, Caroline, et al.
Publicado: (2022)

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Targeted Radionuclide Therapy of Cancer and Infections
por: van der Wal, Bart C. H., et al.
Publicado: (2023)

Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours
por: Weber, Valérie, et al.
Publicado: (2022)

Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
por: Rondon, Aurélie, et al.
Publicado: (2021)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018)

Radioimmunotherapy of malignancy using antibody targeted radionuclides.
por: Cobb, L. M., et al.
Publicado: (1986)

Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2j2iq7p8hv0671sehbk2thtt3h